Alembic Pharmaceuticals is planning to raise funds on Private Placement Basis through issuance of Non-Convertible Debentures (NCDs). The Board of Directors of the Company at its meeting to be held on December 06, 2018 to consider the same.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.
Please share this news